BGT Stock Overview
Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia.
Bio-Gene Technology Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.10|
|52 Week High||AU$0.35|
|52 Week Low||AU$0.09|
|1 Month Change||-16.00%|
|3 Month Change||-4.55%|
|1 Year Change||-47.50%|
|3 Year Change||-48.78%|
|5 Year Change||-47.50%|
|Change since IPO||-47.50%|
Recent News & Updates
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash WiselyFeb 22
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn SituationOct 25
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn SituationJun 20
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near FutureApr 28
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO CompensationJan 11
|BGT||AU Chemicals||AU Market|
Return vs Industry: BGT underperformed the Australian Chemicals industry which returned 2.9% over the past year.
Return vs Market: BGT underperformed the Australian Market which returned -1.8% over the past year.
|BGT Average Weekly Movement||13.4%|
|Chemicals Industry Average Movement||10.0%|
|Market Average Movement||9.0%|
|10% most volatile stocks in AU Market||15.9%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: BGT is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: BGT's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production.
Bio-Gene Technology Limited Fundamentals Summary
|BGT fundamental statistics|
Is BGT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BGT income statement (TTM)|
|Cost of Revenue||AU$223.63k|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.016|
|Net Profit Margin||-653.81%|
How did BGT perform over the long term?See historical performance and comparison